{ "entity_id": "B-002090", "folder": "Gene-Technology-Standing-Committee", "name": "Gene Technology Standing Committee", "type": "Advisory Body", "jurisdiction": "Commonwealth", "portfolio": "Health, Disability and Ageing", "website": "https://www.genetechnology.gov.au/", "data_status": "stub", "completeness": { "has_strategy_brief": false, "has_strategy_structured": true, "has_vision": false, "has_kpi_targets": false, "has_kpi_results": false, "has_strategy_overview": true, "has_legislation_text": true, "has_legislation_structured": false, "has_global_initiatives_text": false, "has_global_initiatives_structured": false, "n_global_initiatives": 0, "has_ideas": true, "has_artifacts": true, "n_ideas": 12, "n_legislation": 0, "n_artifacts": 1, "n_kpi_targets": 0, "n_kpi_results": 0, "n_outcomes": 0, "verified_own_data": true }, "strategy_profile": { "status": "needs_review", "confidence": "medium", "summary": "", "official_site_url": "https://www.genetechnology.gov.au/", "source_documents": [], "purpose": null, "vision": null, "strategic_priorities": [], "values": [], "outcomes": [], "performance_measures": [], "document_alignment_terms": { "must_support": [], "watch_terms": [], "avoid_claiming_without_evidence": [] }, "review_note": "Structured strategy exists but is incomplete." }, "global_initiatives": null, "strategy": { "reporting_period": "2024-25", "corporate_plan_period": "2025-26", "vision": null, "vision_source_page": null, "purposes": null, "purposes_source_page": null, "how_we_deliver": null, "how_we_deliver_source_page": null, "government_priorities": [], "outcomes": [], "values": [], "values_framework_name": null, "kpi_targets_2025_26": [], "kpi_results_2024_25": [], "_source_urls": { "annual_report_url": "", "corporate_plan_url": "" } }, "ideas": [ { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Regulation & Policy", "scale": "small", "title": "Regulatory burden scan for forms, guidance, and reporting", "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.", "quote": "[pages 1,2,3,4,5,6,7,8,9,10,11,12,13,14]\n[Page 1]\nProposed amendments to the Gene\nTechnology Regulations 2001\nAvi Rebera\nAssistant Secretary\nOffice of Drug Control and Gene Technology Policy & Governance\nAustralian Government Department of Health, Disability and Ageing\nGuest speaker\nDanielle Chifley\nDirector – Regulatory Policy and Reform\nOffice of Drug Control and Gene Technology Policy & Governance\nAustralian Government Department of Health, Disability and Ageing\nKirsteen Magee\nDr Raj Bhula\nAssistant Director\nGene Technology Regulator\nGene Technology Policy & Governance\nAustralian Government Department\nAustralian Government Department of Health, Disability and Ageing\nof Health, Disability and Ageing\n1\nwww.genetechnology.gov.au", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.pdf (https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Regulation & Policy", "scale": "large", "title": "Adaptive regulation program with live feedback loops", "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.", "quote": "[pages 1,2,3,4,5,6,7,8,9,10,11,12,13,14]\n[Page 1]\nProposed amendments to the Gene\nTechnology Regulations 2001\nAvi Rebera\nAssistant Secretary\nOffice of Drug Control and Gene Technology Policy & Governance\nAustralian Government Department of Health, Disability and Ageing\nGuest speaker\nDanielle Chifley\nDirector – Regulatory Policy and Reform\nOffice of Drug Control and Gene Technology Policy & Governance\nAustralian Government Department of Health, Disability and Ageing\nKirsteen Magee\nDr Raj Bhula\nAssistant Director\nGene Technology Regulator\nGene Technology Policy & Governance\nAustralian Government Department\nAustralian Government Department of Health, Disability and Ageing\nof Health, Disability and Ageing\n1\nwww.genetechnology.gov.au", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Regulated entities / policy teams", "source": "other-pdfs/information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.pdf (https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Risk & Assurance", "scale": "small", "title": "Recommendation tracker for audits, reviews, and inquiries", "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.", "quote": "[Page 14]\nAuthorisation pathways\n• Major changes to existing authorisation pathways were outlined during consultation on the draft\nBill.\n• It is proposed that entirety of Part 3 and Schedules 2 & 3 of the Regulations will be revoked.\n• The Amendment Regulations will specify classes of GMO dealings using new risk proportionate\nauthorisation pathways.\nrisk-tiering\nlower risk higher risk\nmore streamlined more scrutiny\n• Risk proportionate regulation is common in modern regulatory schemes, maintaining strong\nsafeguards against high-risk dealings, whilst enabling efficiency for low-risk dealings.\n• The Gene Technology Regulator will make rules to specify further requirements to restrict the\nGMO classes.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.pdf (https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Risk & Assurance", "scale": "large", "title": "Integrated assurance and lessons-learned system", "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.", "quote": "[Page 14]\nAuthorisation pathways\n• Major changes to existing authorisation pathways were outlined during consultation on the draft\nBill.\n• It is proposed that entirety of Part 3 and Schedules 2 & 3 of the Regulations will be revoked.\n• The Amendment Regulations will specify classes of GMO dealings using new risk proportionate\nauthorisation pathways.\nrisk-tiering\nlower risk higher risk\nmore streamlined more scrutiny\n• Risk proportionate regulation is common in modern regulatory schemes, maintaining strong\nsafeguards against high-risk dealings, whilst enabling efficiency for low-risk dealings.\n• The Gene Technology Regulator will make rules to specify further requirements to restrict the\nGMO classes.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / assurance teams", "source": "other-pdfs/information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.pdf (https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Regulatory capture", "Over-automation of judgement" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Citizen Participation", "scale": "small", "title": "Consultation feedback summaries with response tracking", "idea": "Summarise consultation submissions by theme and publish what changed in response.", "quote": "Subscribe\nFilter results\nYou can narrow down the results using the filters\nNews type\nGene technology news\n(8)\n10\nresults\nSearch\nConsultation on the proposed amendments to the Gene Technology Regulations 2001\n7 January 2026\nNews\nWe invite stakeholders to provide feedback on proposed amendments to the Gene Technology Regulations.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "pages/news-latest.html (https://www.genetechnology.gov.au/news)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Citizen Participation", "scale": "large", "title": "Always-on policy participation platform", "idea": "Create a standing participation platform where citizens and stakeholders can propose, vote, and track ideas.", "quote": "Subscribe\nFilter results\nYou can narrow down the results using the filters\nNews type\nGene technology news\n(8)\n10\nresults\nSearch\nConsultation on the proposed amendments to the Gene Technology Regulations 2001\n7 January 2026\nNews\nWe invite stakeholders to provide feedback on proposed amendments to the Gene Technology Regulations.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Citizens / stakeholders / policy teams", "source": "pages/news-latest.html (https://www.genetechnology.gov.au/news)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Digital exclusion", "Low public trust if feedback is not acted on" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Staff Productivity", "scale": "small", "title": "Reusable briefing and summary assistant for internal documents", "idea": "Create controlled templates for summarising reports, submissions, minutes, and ministerial briefs.", "quote": "Outcome of the Gene Technology Ministers’ Meeting – July 2021\n31 July 2021\nNews\nThe Gene Technology Ministers’ Meeting (GTMM) met virtually on Tuesday 20 July 2021.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "pages/news-latest.html (https://www.genetechnology.gov.au/news)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Staff Productivity", "scale": "large", "title": "Department-wide knowledge and briefing platform", "idea": "Build a secure knowledge platform that lets staff search, summarise, and cite approved departmental material.", "quote": "Outcome of the Gene Technology Ministers’ Meeting – July 2021\n31 July 2021\nNews\nThe Gene Technology Ministers’ Meeting (GTMM) met virtually on Tuesday 20 July 2021.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "APS staff / executives", "source": "pages/news-latest.html (https://www.genetechnology.gov.au/news)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability", "Sensitive information leakage", "Inconsistent quality of generated drafts" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Data & Performance", "scale": "small", "title": "KPI evidence register with named owners", "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.", "quote": "Outcome of the Gene Technology Ministers’ Meeting – July 2021\n31 July 2021\nNews\nThe Gene Technology Ministers’ Meeting (GTMM) met virtually on Tuesday 20 July 2021.", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "pages/news-latest.html (https://www.genetechnology.gov.au/news)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Data & Performance", "scale": "large", "title": "Outcome dashboard linking budget, delivery, and public impact", "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.", "quote": "Outcome of the Gene Technology Ministers’ Meeting – July 2021\n31 July 2021\nNews\nThe Gene Technology Ministers’ Meeting (GTMM) met virtually on Tuesday 20 July 2021.", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Executives / Parliament / public", "source": "pages/news-latest.html (https://www.genetechnology.gov.au/news)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Case Processing", "scale": "small", "title": "Triage queue for stuck or ageing cases", "idea": "Use existing case data to flag ageing, duplicate, incomplete, or high-risk cases for earlier intervention.", "quote": "Post-notified notifiable dealings Pre-notified notifiable dealings\n• Regulator notification after commencement • Regulator notification prior to\ncommencement\n• Require Institutional Biosafety Committee\n(IBC) assessment • Would cover some currently licenced dealings\n• Regulator rules will prescribe conditions: • Regulations will prescribe:\n- who must notify - who must notify\n- the period in which they must notify - the period in which they must notify\n- form of notification - form of notification\nLower risk\n- any documents required in notification - any documents required in notification\n1 8", "impact": "High", "effort": "Low", "proof": "Evidence-backed", "beneficiaries": "Applicants / case officers", "source": "other-pdfs/information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.pdf (https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf)", "implementation": [ "Pick one high-volume process or document family.", "Name an owner and baseline current volume, time, cost, and satisfaction.", "Run a 4-8 week pilot with clear before/after metrics.", "Publish lessons and decide whether to scale." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] }, { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "category": "Case Processing", "scale": "large", "title": "End-to-end case processing redesign", "idea": "Redesign the case pathway around risk-based triage, reusable evidence, and automated eligibility checks.", "quote": "Post-notified notifiable dealings Pre-notified notifiable dealings\n• Regulator notification after commencement • Regulator notification prior to\ncommencement\n• Require Institutional Biosafety Committee\n(IBC) assessment • Would cover some currently licenced dealings\n• Regulator rules will prescribe conditions: • Regulations will prescribe:\n- who must notify - who must notify\n- the period in which they must notify - the period in which they must notify\n- form of notification - form of notification\nLower risk\n- any documents required in notification - any documents required in notification\n1 8", "impact": "Very High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Applicants / case officers", "source": "other-pdfs/information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.pdf (https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf)", "implementation": [ "Create a senior responsible owner and cross-functional delivery team.", "Map legislation, data, privacy, procurement, cyber, and workforce constraints.", "Co-design with users and frontline staff before technology selection.", "Stage delivery through pilots, benefits tracking, and public reporting." ], "risks": [ "Privacy and data quality", "Change fatigue", "Unclear accountability" ] } ], "legislation_administered": [], "artifacts": [ { "category": "other-pdfs", "year": "2026", "url": "https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf", "file": "other-pdfs/information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.pdf", "bytes": 1977929, "link_text": "Download [Publication] Information session on proposed amendments to the Gene Technology Regulations 2001 (PDF) as PDF - 1.89 MB\n - 28 pages" } ], "_meta": { "snapshot_built_at": "2026-05-14T02:12:56+00:00", "strategy_brief_meta": { "model": "nova-micro", "folder": "Gene-Technology-Standing-Committee", "annual_report": { "file": null, "url": "", "year": null }, "corporate_plan": { "file": "other-pdfs\\information-session-on-proposed-amendments-to-the-gene-technology-regulations-20.txt", "url": "https://www.genetechnology.gov.au/sites/default/files/2026-02/information-session-on-proposed-amendments-to-the-gene-technology-regulations-2001.pdf", "year": null }, "usage": { "input_tokens": 4574, "output_tokens": 155, "total_tokens": 4729, "model": "nova-micro" }, "cost_usd": 0.00018179000000000003, "elapsed_seconds": 16.23, "generated_at": "2026-05-13T05:16:58+00:00" }, "ideas_manifest": { "entity_id": "B-002090", "entity_name": "Gene Technology Standing Committee", "folder_name": "Gene-Technology-Standing-Committee", "generated_at": "2026-05-09T23:05:36.539532+00:00", "idea_count": 12, "markdown": "ideas/Gene-Technology-Standing-Committee_ideas.md", "jsonl": "ideas/ideas.jsonl", "inputs": [ "Gene-Technology-Standing-Committee_strategy-overview.md", "strategy-evidence.json", "global-intelligence/source-manifest.json" ] }, "global_intel_meta": null } }